Arama Sonuçları - P.F. Buckley

Sonuçları Daraltın
  1. 1
    Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?

    Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac? Yazar: P.F. Buckley, Stephen M. Stahl

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Meta-Analysis of Oxidative Stress in Schizophrenia

    Meta-Analysis of Oxidative Stress in Schizophrenia Yazar: Joshua Flatow, P.F. Buckley, Brian J. Miller

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Psychiatric Comorbidities and Schizophrenia

    Psychiatric Comorbidities and Schizophrenia Yazar: P.F. Buckley, Brian J. Miller, Douglas S. Lehrer, David Castle

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Actigraphy Correctly Predicts Sleep Behavior in Infants Who Are Younger than Six Months, When Compared with Polysomnography

    Actigraphy Correctly Predicts Sleep Behavior in Infants Who Are Younger than Six Months, When Compared with Polysomnography Yazar: Kevin So, P.F. Buckley, T. M. Adamson, Rosemary S.C. Horne

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    An Open-Label, Pilot Trial of Adjunctive Tocilizumab in Schizophrenia

    An Open-Label, Pilot Trial of Adjunctive Tocilizumab in Schizophrenia Yazar: Brian J. Miller, James K. Dias, Henrique Lemos, P.F. Buckley

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation

    Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation Yazar: P.F. Buckley, Reginald Bell, Kate S. Freeman, Stephanie Doggett, Rachel Heidrick

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Biomarkers in Schizophrenia: A Brief Conceptual Consideration

    Biomarkers in Schizophrenia: A Brief Conceptual Consideration Yazar: Cynthia Shannon Weickert, Thomas W. Weickert, Anil K. Pillai, P.F. Buckley

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects

    Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects Yazar: Brian J. Miller, Bintou Gassama, Dale Sebastian, P.F. Buckley, Andrew L. Mellor

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Brain derived neurotropic factor in first-episode psychosis

    Brain derived neurotropic factor in first-episode psychosis Yazar: P.F. Buckley, Anilkumar Pillai, Denise R. Evans, Edna Stirewalt, Sahebarao P. Mahadik

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

    Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects Yazar: Brian J. Miller, P.F. Buckley, Wesley Seabolt, Andrew L. Mellor, Brian Kirkpatrick

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Insomnia and suicidal ideation in nonaffective psychosis

    Insomnia and suicidal ideation in nonaffective psychosis Yazar: Brian J. Miller, Carmen Black, Mark Hyman Rapaport, P.F. Buckley, W. Vaughn McCall

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus

    Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus Yazar: Masoud Panjehpour, B. F. Overholt, Tuan Vo‐Dinh, R C Haggitt, DH Edwards, P.F. Buckley

    Baskı/Yayın Bilgisi 1996
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia

    TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia Yazar: David R. Goldsmith, Ebrahim Haroon, Andrew H. Miller, Gregory P. Strauss, P.F. Buckley, Brian J. Miller

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study.

    Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. Yazar: E. O’Callaghan, Terri Gibson, Hubert A. Colohan, P.F. Buckley, David Walshe, C. Larkin, John L. Waddington

    Baskı/Yayın Bilgisi 1992
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics

    Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics Yazar: J P McEvoy, Rebecca Baillie, Hongjie Zhu, P.F. Buckley, Matcheri S. Keshavan, Henry A. Nasrallah, George G. Dougherty, Jeffrey Yao, Rima Kaddurah‐Daouk

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia

    Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia Yazar: Joseph P. McEvoy, Matthew Byerly, Robert M. Hamer, Rosalie Dominik, Marvin S. Swartz, Robert A. Rosenheck, Neepa Ray, J. Steven Lamberti, P.F. Buckley, Tania M Wilkins, T. Scott Stroup

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia

    The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia Yazar: George A. Keepers, Laura J. Fochtmann, Joan M. Anzia, Sheldon Benjamin, Jeffrey M. Lyness, Ramin Mojtabai, Mark Servis, Art Walaszek, P.F. Buckley, Mark F. Lenzenweger, Alexander S. Young, Amanda Degenhardt, Seung-Hee Hong

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia

    The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia Yazar: George A. Keepers, Laura J. Fochtmann, Joan M. Anzia, Sheldon Benjamin, Jeffrey M. Lyness, Ramin Mojtabai, Mark Servis, Art Walaszek, P.F. Buckley, Mark F. Lenzenweger, Alexander S. Young, Amanda Degenhardt, Seung-Hee Hong

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Comparison of SGA Oral Medications and a Long-Acting Injectable SGA: The PROACTIVE Study

    Comparison of SGA Oral Medications and a Long-Acting Injectable SGA: The PROACTIVE Study Yazar: P.F. Buckley, Nina R. Schooler, Donald Goff, John Hsiao, Alexander Kopelowicz, John Lauriello, Theo C. Manschreck, Alan Mendelowitz, Del D. Miller, Joanne B. Severe, Daniel R. Wilson, Donna Ames, Juan Bustillo, Jim Mintz, John M. Kane

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

    Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial Yazar: Richard S.E. Keefe, Sophia Vinogradov, Alice Medalia, P.F. Buckley, Stanley N. Caroff, Deepak Cyril D’Souza, P.D. Harvey, Karen A. Graham, Robert M. Hamer, Stephen Marder, Del D. Miller, Stephen J. Olson, Jayendra K. Patel, Dawn I. Velligan, Trina M. Walker, Adam Haim, T. Scott Stroup

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: